多中心长期真实世界数据,关于1型原发性高氧化患者用卢马西兰治疗的数据
Cristina Martin-Higueras1,2, Lodovica Borghese1, Armando Torres2,3
1German Hyperoxaluria Center, c/o Kindernierenzentrum Bonn, Germany.
Kidney international reports
|February 5, 2024
概括
卢马西兰有效地降低了原发性高氧化尿1型 (PH1) 患者的氧酸盐产量,改善了功能. 需要进一步的研究来优化剂量和管理透析患者的潜在酸载荷.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 初级高氧化尿1型 (PH1) 是一种罕见的遗传疾病,其特征是过度的氧化酸盐生产.
- 卢马西兰是一种RNA干扰 (RNAi) 治疗药物,向肝脏氧沙酸盐合成.
- 在临床试验之外对卢马西兰有效性的现实数据有限.
研究的目的:
- 评估在PH1患者中卢马西兰的实际有效性和安全性.
- 评估卢马西兰对尿液和血中氧化酸盐水平,功能和临床结果的影响.
- 调查卢马西兰在患有保存功能和透析患者中的作用.
主要方法:
- 对33名PH1患者进行了回顾性和观察性研究,这些患者接受了中位数18个月的卢马西兰治疗.
- 数据收集包括尿氧酸 (Uox),血氧酸 (Pox),血糖酸 (Pglyc) 和功能参数.
- 患者被分为保存功能和透析患者的两组.
主要成果:
- 在有保存功能的患者中,Uox显著降低,膜过率改善. 维生素B6 (VB6) 药物影响了反应.
- 血氧沙酸 (Pox) 在功能保留的患者中保持稳定,但在透析患者中随着每月剂量增加而下降.
- 所有患者的尿液和血糖酸 (Uglyc,Pglyc) 都显著增加,需要调整药物治疗. 系统性氧化没有变化.
结论:
- 卢马西兰是一种安全有效的PH1治疗方法,可以减少肝脏的氧沙酸盐产量.
- 剂量间隔和糖水平升高的管理需要进一步调查,特别是在透析患者.
- 在透析患者中缺少小症的减少可能与溶解系统性氧沙酸盐沉积物有关.
更多相关视频
05:56Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases
Published on: January 9, 2019
7.9K
11:06Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
4.4K
相关概念视频
01:11Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248